
Summary
Molmart Limited is a genomics company developing a potentially life-changing diagnostic technology for sufferers of an undiagnosed genetic disorder. Rare diseases currently affect an estimated 350 million people worldwide, some of which have the potential to be severely life threatening or life-compromising.
https://globalgenes.org/rare-diseases-facts-statistics/[LP1] [LT2]
The Company is focused on furthering the capabilities of Whole Genome Sequencing (‘WGS’), the process of determining the complete DNA sequence of an organism's genome at a single time (Genoma, “What is Whole Genome Sequencing?”, 2018).
Product
Sector
Status
HMRC
Advanced AssuranceCompany Website
http://molmart.co.uk/
